Structure Therapeutics Inc. (GPCR) Tops Q3 EPS by 1c

Structure Therapeutics Inc. (NASDAQ: GPCR) reported Q3 EPS of ($0.21), $0.01 better than the analyst estimate of ($0.22).

For earnings history and earnings-related data on Structure Therapeutics Inc. (GPCR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Reading (RDI) Tops Q2 EPS by 4c